TARGET RWE

Target RWE is redefining and revolutionizing the generation and delivery of real-world evidence. With high-quality and comprehensive fit-for-use datasets captured across a broad range of chronic illnesses, Target RWE is well-positioned to support pharmaceutical, industry, life sciences, and healthcare partners with their RWE initiatives and programs... Target RWE was created in 2015 as an outcome of the success of HCV-TARGET, a case study of the Target RWE Model for hepatitis C. HCV-TARGET was a partnership between academia, the FDA and industry established in 2011 by Michael W. Fried, MD, FAASLD and David R. Nelson, MD. To date, the study has enrolled over 16,000+ patients across 60 sites in North America and Europe... Target RWE's cross-sectional and longitudinally complete registries encompass diverse patient populations beyond those traditionally captured in Phase 2 and 3 trials, generating more meaningful evidence on product effectiveness and safety in the real world. We provide..

Primary location: Durham United States